Essex University Southend University Hospital, Westcliff-on-Sea, Essex.
Clin Med (Lond). 2010 Aug;10(4):381-6. doi: 10.7861/clinmedicine.10-4-381.
Giant cell arteritis (GCA) or temporal arteritis (TA) with polymyalgia rheumatica (PMR) is among the most common reasons for long-term steroid prescription. GCA is a critically ischaemic disease, the most common form of vasculitis and should be treated as a medical emergency. Visual loss occurs in up to a fifth of patients, which may be preventable by prompt recognition and treatment. The British Society for Rheumatology (BSR) and the British Health Professionals in Rheumatology (BHPR) have recently published guidelines on the management of PMR. The purpose of this concise guidance is to draw attention to the full guidelines to encourage the prompt diagnosis and urgent management of GCA, with emphasis on the prevention of visual loss. They provide a framework for disease assessment, immediate treatment and referral to specialist care for management and monitoring of disease activity, complications and relapse.
巨细胞动脉炎（GCA）或伴有多发性肌痛的颞动脉炎（TA）是长期使用类固醇处方的最常见原因之一。GCA 是一种严重缺血性疾病，是最常见的血管炎形式，应作为医疗急症进行治疗。多达五分之一的患者会出现视力丧失，而及时识别和治疗可能会预防这种情况。英国风湿病学会（BSR）和英国风湿病专业人员（BHPR）最近发布了关于 PMR 管理的指南。本简明指南的目的是提请注意完整的指南，以鼓励及时诊断和紧急管理 GCA，并强调预防视力丧失。它们为疾病评估、立即治疗以及向专家护理转诊以管理和监测疾病活动、并发症和复发提供了一个框架。
